Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Stockholders' Equity (Unaudited)

v3.23.1
Condensed Consolidated Statement of Stockholders' Equity (Unaudited) - USD ($)
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
AOCI Attributable to Parent [Member]
Beginning balance, value at Dec. 31, 2021 $ 69,108,027 $ 416 $ 418,903,820 $ (349,733,764) $ (62,445)
Beginning balance, shares at Dec. 31, 2021   4,169,631      
Issuance of common stock, net of issuance costs 1 $ 1      
Issuance of common stock, net of issuance costs, shares   833      
Stock-based compensation expense 1,591,746   1,591,746    
Unrealized loss on marketable debt securities (107,248)       (107,248)
Net loss (9,437,242)     (9,437,242)  
Ending balance, value at Mar. 31, 2022 61,155,284 $ 417 420,495,566 (359,171,006) (169,693)
Ending balance, shares at Mar. 31, 2022   4,170,464      
Beginning balance, value at Dec. 31, 2022 32,990,017 $ 417 425,196,359 (392,080,667) (126,092)
Beginning balance, shares at Dec. 31, 2022   4,171,297      
Stock-based compensation expense 1,026,379   1,026,379    
Issuance of common stock upon exercise of stock options $ 129,745 $ 5 129,740    
Issuance of common stock upon exercise of stock options, shares 43,836 43,836      
Unrealized loss on marketable debt securities $ 57,623       57,623
Net loss (17,744,812)     (17,744,812)  
Ending balance, value at Mar. 31, 2023 $ 16,458,952 $ 422 $ 426,352,478 $ (409,825,479) $ (68,469)
Ending balance, shares at Mar. 31, 2023   4,215,133